BACKGROUND EZETIMIBE USE AMONG PARTICIPANTS IN THE CLEAR OUTCOMES TRIAL

BACKGROUND EZETIMIBE USE AMONG PARTICIPANTS IN THE CLEAR OUTCOMES TRIAL

Therapeutic Area: ASCVD/CVD Risk Reduction Background: The Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial randomized statin-intolerant patients with, or at high risk for, atherosclerotic cardiovascular disease (ASCVD) to bempedoic acid or placebo and assess...

Full description

Bibliographic Details
Main Authors: Luke J. Laffin, Danielle Brennan, LeAnne Bloedon, Na Li, Steven E. Nissen
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:American Journal of Preventive Cardiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667723000922

Internet

http://www.sciencedirect.com/science/article/pii/S2666667723000922

Similar Items